Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.

Amanda McCann, P. Dervan, M O'Regan, +4

PubMed

Poorer PrognosisBreast OncologyMedicineImmunologyGynecology +11

Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.

S P Ethier, Michael L. Mahacek, W.J. Gullick, +2

PubMed

Breast OncologyPathologyCell CultureCell ProliferationBreast Cancer Specimens +17

Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.

W.J. Gullick, Julian Downward, Michael D. Waterfield

The EMBO Journal

Autophosphorylation SitesSignal TransductionSignaling PathwayReceptor Tyrosine KinaseImmunology +7

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.

Giampietro Gasparini, W.J. Gullick, Pierantonio Bevilacqua, +6

Journal of Clinical Oncology

Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines

Josephine C. Adams, W.J. Gullick

Biochemical Journal

Whereas Tpa TreatmentMolecular RegulationImmunologyImmunotherapyCellular Physiology +16

Association of Epidermal Growth Factor-related Peptides and Type I Receptor Tyrosine Kinase Receptors with Prognosis of Human Colorectal Carcinomas

Toshiaki Saeki, David S. Salomon, Gibbes R. Johnson, +7

Japanese Journal of Clinical Oncology

MedicineReceptor Tyrosine KinaseCancer GrowthColorectal CancerPathology +8

Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.

Rafael Molina, Daniel R. Ciocca, Amol Tandon, +5

PubMed

Breast OncologyImmunologyImmunoeditingPathologyHuman Breast Cancer +18

c-erbB3 protein expression in ovarian cancer

Thangarajan Rajkumar, Gordon Stamp, Christine M. Hughes, +1

Molecular Pathology

Expression of the c‐erbB‐3 gene product in gastric cancer

Elias Sanidas, M. I. Filipe, Jacqueline M. Linehan, +4

International Journal of Cancer

Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity.

G R Johnson, S A Prigent, W.J. Gullick, +1

Journal of Biological Chemistry

Epidermal Growth FactorAldo-keto ReductaseGlycobiologyMolecular BiologyChemical Biology +16